Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathy
Abstract We developed a highly sensitive and specific single-molecule array (Simoa) Homebrew assay for quantification of phosphorylated α-synuclein at serine 129 (pS129 α-syn) and evaluated its performance in human cerebrospinal fluid (CSF) and plasma. Using a cohort of patients with Parkinson’s dis...
Saved in:
| Main Authors: | Giovanni Bellomo, Erik Stoops, Jeroen Vanbrabant, Leentje Demeyer, Cindy Francois, Melanie Vanhooren, Yihua Ma, Carly M. Farris, Luis Concha-Marambio, Federico Paolini Paoletti, Lorenzo Gaetani, Lucilla Parnetti, Davide Chiasserini |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | npj Parkinson's Disease |
| Online Access: | https://doi.org/10.1038/s41531-025-01086-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer’s disease and Parkinson’s disease
by: Lorenzo Gaetani, et al.
Published: (2025-05-01) -
New CSF biomarkers on the block
by: Charlotte E Teunissen, et al.
Published: (2016-09-01) -
Alpha-Synuclein Dysregulation in Systemic Pathophysiology of Synucleinopathies
by: Hallie H. Dolin, et al.
Published: (2025-07-01) -
Studying Alzheimer’s disease through an integrative serum metabolomic and lipoproteomic approach
by: Alessia Vignoli, et al.
Published: (2025-01-01) -
Clinical utility of synuclein skin biopsy in the diagnosis and evaluation of synucleinopathies
by: Jonathan R. Isaacson, et al.
Published: (2024-12-01)